• OPEN AN ACCOUNT
Indian Indices
Sensex
72,162.87 253.17
( 0.35%)
Global Indices
Nasdaq
51,190.24 242.68
(0.48%)
Dow Jones
7,742.36 54.91
(0.71%)
Hang Seng
68,256.51 -700.21
(-1.02%)
Nikkei 225
10,455.36 27.09
(0.26%)
Forex
USD-INR
96.17 0.25
(0.26%)
EUR-INR
108.49 -0.30
(-0.28%)
GBP-INR
127.16 -0.03
(-0.02%)
JPY-INR
0.61 0.00
(-0.36%)

EQUITY - MARKET SCREENER

Jubilant Pharmova Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
530019
INE700A01033
145.1556811
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
JUBLPHARMA
0
15940.35
EPS(TTM)
Face Value()
Div & Yield %
1.98
1
0.5
 

hindustan unilever ltd
Gravita India consolidated net profit declines 3.42% in the March 2026 quarter
May 08,2026
Net profit of Gravita India declined 3.42% to Rs 91.88 crore in the quarter ended March 2026 as against Rs 95.13 crore during the previous quarter ended March 2025. Sales rose 13.08% to Rs 1172.76 crore in the quarter ended March 2026 as against Rs 1037.07 crore during the previous quarter ended March 2025.

For the full year,net profit rose 21.26% to Rs 378.80 crore in the year ended March 2026 as against Rs 312.39 crore during the previous year ended March 2025. Sales rose 10.25% to Rs 4265.27 crore in the year ended March 2026 as against Rs 3868.77 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1172.761037.07 13 4265.273868.77 10
OPM %9.598.89 -10.208.38 -
PBDT117.00122.32 -4 487.08392.55 24
PBT105.95114.57 -8 448.25363.46 23
NP91.8895.13 -3 378.80312.39 21